Cortical Blindness (Anton Syndrome)

Subscribe to Selected New Research on Cortical Blindness

130 relevant articles (3 outcomes, 5 trials/studies) found for this Disease

Description: Total loss of vision in all or part of the visual field due to bilateral OCCIPITAL LOBE (i.e., VISUAL CORTEX) damage or dysfunction. Anton syndrome is characterized by the psychic denial of true, organic cortical blindness. (Adams et al., Principles of Neurology, 6th ed, p460)

Also Known As:

Anton Syndrome; Syndrome, Anton; Blindness, Cortical; Blindness, Cortical, Post-Ictal; Blindness, Cortical, Transient; Anton Syndromes; Syndromes, Anton; Psychic Denial of Blindness

Relationship Network

Disease Context: Research Results

Nervous System Diseases: 3643

Neurologic Manifestations: 3015

Sensation Disorders: 52

Vision Disorders: 112

Blindness: 2144

Cortical Blindness: 130

Eye Diseases: 1323

Vision Disorders: 112

Blindness: 2144

Cortical Blindness: 130

Signs and Symptoms Pathological Conditions

Signs and Symptoms

Neurologic Manifestations: 3015

Sensation Disorders: 52

Vision Disorders: 112

Blindness: 2144

Cortical Blindness: 130

Related Diseases

1.	Poisoning
2.	Acute Kidney Failure (Acute Renal Failure)
3.	Pneumonia (Pneumonitis)
4.	Seizures (Seizure)
5.	Coma (Comas)

Experts

1.	Yazici, Mehmet: 1 article (01/2007)
2.	Kinay, Ozan: 1 article (01/2007)
3.	Kilicaslan, Baris: 1 article (01/2007)
4.	Karaca, Mustafa: 1 article (01/2007)
5.	Cece, Hasan: 1 article (01/2007)
6.	Biceroglu, Serdar: 1 article (01/2007)
7.	Ergene, Oktay: 1 article (01/2007)
8.	Ozhan, Hakan: 1 article (01/2007)
9.	Manchana, Tarinee: 1 article (08/2006)
10.	Tresukosol, Damrong: 1 article (08/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Cortical Blindness:

1.	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/01/1988 - "Neurologic abnormalities, including cortical blindness, resolved completely after discontinuation of cyclosporin A. " 11/01/1997 - "Persistent cortical blindness after cyclosporine leukoencephalopathy." 02/01/1997 - "We report two cases of encephalopathy with cortical blindness associated with reversible bioccipital lesions in transplanted patients (of the kidney and bone marrow) who were being treated with cyclosporin A. " 02/01/1997 - "[Reversible cortical blindness associated with bilateral occipital lesions caused by cyclosporin A: report of two cases]" 10/08/1994 - "Eighteen cases of cortical blindness during cyclosporin treatment are now known in the literature. " Order ALL the reference details at left...
2.	Carbon MonoxideIBA 01/01/2005 - "The authors found this case of interest because cortical blindness due to CO intoxication is only rarely seen with a relatively good outcome." 01/01/2005 - "Partial recovery from cortical blindness following carbon monoxide intoxication." 02/01/1987 - "We report a case of cortical blindness occurring 7 days after acute CO poisoning with no other neurological or psychic deficits apart from denial of the blindness with visual confabulation and slight loss of retentive memory. " 01/01/2009 - "CLINICAL PRESENTATION AND INTERVENTION: A 21-year-old woman poisoned with CO (with coma lasting 4 h and carboxyhemoglobin level 46%) developed seizures and cortical blindness 3 days after poisoning. " Order ALL the reference details at left...
3.	Anti-Bacterial Agents (Antibiotics)IBA 08/01/2000 - "Several days later, her pneumonia improved on treatment with antibiotics, but she suddenly developed transient cortical blindness and acute renal failure. " Order ALL the reference details at left...
4.	Contrast MediaIBA 01/01/1992 - "Low osmolar and non-ionic X-ray contrast media and cortical blindness." 01/01/2007 - "The occurrence rate of transient cortical blindness after contrast media exposure has been reported to be as high as 1% to 4% after cerebral or vertebral angiography, but such blindness has been described in only a few cases of coronary angiography with modern, non-ionic, low-osmolality radio-contrast agents. " 02/01/2000 - "This case emphasizes that cortical blindness associated with angiography does not always have a favorable outcome, since it might be, in rare cases, due to isolated occipital embolisms, which initially produce a clinical picture identical to that of the neurotoxic effect of contrast agents." 03/01/1999 - "In the reported cases, convulsions and transient cortical blindness due to non-ionic low osmolar contrast materials is a rare complication. " 01/01/2007 - "In this study, we present a case of abrupt cortical blindness after exposure to contrast media during diagnostic coronary angiography; to our knowledge, this is the 1st report in the medical literature that describes transient cortical blindness after iobitridol use." Order ALL the reference details at left...
5.	SilverIBA 11/01/1992 - "Golgi-Kopsch silver study of the brain of a patient with untreated phenylketonuria, seizures, and cortical blindness." Order ALL the reference details at left...
6.	iobitridolIBA 01/01/2007 - "Transient cortical blindness after cardiac catheterization with iobitridol." 01/01/2007 - "In this study, we present a case of abrupt cortical blindness after exposure to contrast media during diagnostic coronary angiography; to our knowledge, this is the 1st report in the medical literature that describes transient cortical blindness after iobitridol use." Order ALL the reference details at left...
7.	Retinaldehyde (Retinal)IBA 01/16/1976 - "Cortical blindness after overlapping retinal-striate lesions: a limit to plasticity in the central visual system." 11/01/2009 - "Rates of POVL, defined as any discharge with an International Classification of Diseases, Ninth Revision, Clinical Modification code of ischemic optic neuropathy (ION), cortical blindness (CB), or retinal vascular occlusion (RVO), were estimated. " 02/01/2003 - "The differential diagnosis of acute loss of vision in children includes acute loss of vision due to retinal or optic nerve disease, and cortical blindness. " 11/01/1993 - "It can injure the visual system by damaging the retinal cells, causing bilateral optic neuritis and cortical blindness. " 09/01/1986 - "We describe three cases of NAE with the ocular manifestations of visual loss, cells in the vitreous, retinal artery occlusion, retinal vascular and pigment epithelial alterations, nystagmus, and cortical blindness. " Order ALL the reference details at left...
8.	Cisplatin (Platino)FDA LinkGeneric 01/01/1999 - "Cortical blindness as a manifestation of hypomagnesemia secondary to cisplatin therapy: case report and review of literature." 10/01/1981 - "Cisplatin-associated cortical blindness." 01/01/1993 - "Cortical blindness and seizures following cisplatin treatment: both of epileptic origin?" 02/16/1991 - "Convulsions and transient cortical blindness after cisplatin." 02/15/1980 - "Seizures and transient cortical blindness associated with cis-platinum (II) diamminedichloride (PDD) therapy in a thirty-year-old man." Order ALL the reference details at left...
9.	Tacrolimus (Prograf)FDA Link 11/01/1993 - "Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation." 05/01/1999 - "Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation." 05/01/1999 - "A 54-year-old woman with a myelodysplastic syndrome treated with high-dose chemotherapy and an allogenic bone marrow transplant developed acute cortical blindness while receiving tacrolimus (FK506). " 10/01/2004 - "A 46-year-old woman with Hodgkin's disease who underwent nonmyeloablative allogeneic stem cell transplantation developed cortical blindness, seizures, and left hemiparesis on day 100 while receiving tacrolimus (FK506) and prednisone for the treatment of graft-versus-host disease (GVHD). " Order ALL the reference details at left...
10.	Vincristine (Oncovin)FDA LinkGeneric 11/01/2003 - "Transient cortical blindness following vincristine therapy." 08/01/1992 - "The temporal relationship between vincristine treatment and cortical blindness implicates vincristine as the possible causative agent for this catastrophic phenomenon." 08/01/1992 - "Cortical blindness--a catastrophic side effect of vincristine." 01/01/1981 - "Transient cortical blindness has not previously been attributed to vincristine sulfate therapy, but must be considered as a possible complication of treatment with this agent." 01/01/1981 - "Transient cortical blindness secondary to vincristine therapy in childhood malignancies." Order ALL the reference details at left...

Therapies and Procedures

1.	Transplants (Transplant) 07/01/2002 - "Transient cortical blindness related to coronary angiography and graft study." 07/01/2009 - "Transient cortical blindness is rarely encountered after angiography of native coronary arteries or bypass grafts. " 08/01/2000 - "A 64-year-old man experienced transient cortical blindness after subclavian arteriography for an occluded axillofemoral graft. " 04/01/2000 - "In this report, we describe a seventy-six-year-old male patient who had cortical blindness after coronary bypass graft angiography. " 11/24/1995 - "Two cases of transient cortical blindness during coronary and graft angiography are described. " Order ALL the reference details at left...
2.	Drug Therapy (Chemotherapy) 03/01/1990 - "Cortical blindness during chemotherapy: clinical, CT, and MR correlations." 01/01/1981 - "Three children with malignancies developed severe neurotoxicity, including transient cortical blindness, following chemotherapy regimens. " 08/01/2006 - "Transient cortical blindness during chemotherapy (PVB) for ovarian germ cell tumor." 07/01/1992 - "VEPs in pediatric patients have the following main purposes: (1) detecting lesions causing dysfunction of the sensory visual pathways (the VEP is a sensitive indicator of subclinical lesions and can be used to differentiate visual impairment from visual inattention in young infants); (2) confirming functional loss when disorders of the visual system are present; (3) quantifying visual impairment in patients with known visual disorders, accomplished either empirically by noting the severity of the VEP abnormality to flash and pattern stimuli or by visual acuity estimation studies (early quantification of vision loss allows referral to early intervention programs, which can ameliorate the long-term consequences of the disability); (4) monitoring patients who are at risk for visual complications either from diseases (such as hydrocephalus or neurofibromatosis) or as a complication of therapeutic intervention (e.g., neurosurgery, chemotherapy) to help detect and avoid long-term sequelae of such therapies on the developing nervous system; (5) establishing prognosis for visual and systemic recovery based on flash VEPs for specific pediatric disorders including perinatal asphyxia in full-term neonates, acute-onset cortical blindness, and, to a fair extent, in comatose children; and (6) in some cases, contributing to the differential diagnosis. " 08/01/1992 - "Cortical blindness was diagnosed in a 67 year old woman with leiomyosarcoma of the large bowel, treated by vincristine-containing chemotherapy. " Order ALL the reference details at left...
3.	Phototherapy (Light Therapy) 12/01/1996 - "The present study evaluated the effects of bright light therapy on a patient with cortical blindness. " Order ALL the reference details at left...
4.	Transplantation (Transplant Recipients) 11/01/1997 - "We present a case of a liver transplant recipient in whom discontinuation of CyA therapy has resulted in only partial clinical improvement, and cortical blindness remains after 1 year of follow-up. " 10/01/1991 - "OA-cortical PCA (calcarine artery) anastomosis is an alternative to omentum transplantation or occipital burr hole procedures for impending cortical blindness." 06/01/2003 - "This report presents a case of reversible cortical blindness after lung transplantation, then details the risk factors and clinical course of 28 previously well-documented cases of CYA-induced cortical blindness after transplantation. " 10/01/2004 - "The combined adverse maternal outcomes included maternal death; 1 or more of hepatic failure, hematoma, or rupture; Glasgow coma scale <13; stroke; 2 or more seizures; cortical blindness; positive inotrope support; myocardial infarction; infusion of any third antihypertensive; dialysis; renal transplantation; > or =50% FIO2 for >1 hour; intubation; or transfusion of > or =10 units of blood products. " 02/01/1995 - "We report the occurrence of reversible cyclosporine-induced cortical blindness in three allogeneic bone marrow transplant recipients. " Order ALL the reference details at left...
5.	Renal Dialysis (Hemodialysis) 09/01/2001 - "We recently observed cortical blindness caused by bilateral occipital infarcts in a patient after hemodialysis." 11/01/1978 - "Cortical blindness as a complication of hemodialysis." 09/01/2001 - "Cortical blindness as a complication of hemodialysis is not widely known, though visual disturbances related to uremia have been known for a long time. " 05/01/2004 - "Although cortical blindness secondary to stroke has been reported as a complication after hemodialysis, we were unable to find another report of visual loss secondary to stroke attributed to intradialytic hypotension with preceding episodes of transient visual loss. " 10/01/2004 - "The combined adverse maternal outcomes included maternal death; 1 or more of hepatic failure, hematoma, or rupture; Glasgow coma scale <13; stroke; 2 or more seizures; cortical blindness; positive inotrope support; myocardial infarction; infusion of any third antihypertensive; dialysis; renal transplantation; > or =50% FIO2 for >1 hour; intubation; or transfusion of > or =10 units of blood products. " Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Cortical Blindness

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 3 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>